Merck (BUE:MRK) Cyclically Adjusted Book per Share: ARS5,103.08 (As of Mar. 2026)


BUE:MRK Merck & Co Inc BUE:MRK
71 GF Score
Price ARS38,720.00
GF Value ARS36,249.74
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck Cyclically Adjusted Book per Share?

Merck BUE:MRK -2.22% 71 Cyclically Adjusted Book per Share is ARS5,103.08 as of Mar. 2026. GuruFocus rates BUE:MRK with a GF Score™ of 71/100 and a GF Value™ of ARS36,249.74 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Merck's adjusted book value per share for the three months ended in Mar. 2026 was ARS259,743.888. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS5,103.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merck's average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Merck was 11.30% per year. The lowest was -1.00% per year. And the median was 6.40% per year.

As of today (2026-07-13), Merck's current stock price is ARS38720.00. Merck's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ARS5,103.08. Merck's Cyclically Adjusted PB Ratio of today is 7.59.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.74.


Merck  (BUE:MRK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=38720.00/5103.08
=7.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.74.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Merck Cyclically Adjusted Book per Share Related Terms


Merck Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Merck's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck Cyclically Adjusted Book per Share Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 664.49 1,144.62 3,277.84 3,974.81 5,250.18

Merck Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,477.06 4,155.92 5,281.12 5,250.18 5,103.08

BUE:MRK vs AMGN, ABBV, GILD: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Merck's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Cyclically Adjusted PB Ratio falls into.


BUE:MRK
71GF Score
Merck & Co Inc BUE:MRK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=259743.888/330.2130*330.2130
=259,743.888

Current CPI (Mar. 2026) = 330.2130.

Merck Quarterly Data

Book Value per Share CPI Adj_Book
201606 2,191.613 241.018 3,002.677
201609 2,362.776 241.428 3,231.685
201612 2,311.959 241.432 3,162.128
201703 2,241.126 243.801 3,035.463
201706 2,385.900 244.955 3,216.326
201709 2,458.329 246.819 3,288.937
201712 2,431.371 246.524 3,256.763
201803 2,519.523 249.554 3,333.865
201806 3,038.431 251.989 3,981.640
201809 4,487.453 252.439 5,869.994
201812 3,883.271 251.233 5,104.053
201903 4,167.520 254.202 5,413.684
201906 4,810.286 256.143 6,201.298
201909 5,883.993 256.759 7,567.295
201912 6,099.025 256.974 7,837.281
202003 6,444.214 258.115 8,244.245
202006 7,482.183 257.797 9,583.952
202009 8,565.115 260.280 10,866.422
202012 8,142.728 260.474 10,322.852
202103 9,588.771 264.877 11,953.989
202106 12,452.633 271.696 15,134.641
202109 13,859.381 274.310 16,683.853
202112 15,256.378 278.802 18,069.649
202203 17,361.677 287.504 19,940.771
202206 20,540.856 296.311 22,891.009
202209 24,383.890 296.808 27,128.236
202212 30,381.826 296.797 33,802.477
202303 36,462.027 301.836 39,889.991
202306 36,568.521 305.109 39,577.335
202309 56,932.493 307.789 61,080.316
202312 53,588.957 306.746 57,688.675
202403 134,270.425 312.332 141,957.404
202406 153,915.881 314.175 161,772.976
202409 167,056.272 315.301 174,957.113
202412 185,058.515 315.605 193,624.079
202503 204,790.370 319.799 211,459.205
202506 232,372.606 322.561 237,885.099
202509 283,084.178 324.800 287,801.957
202512 308,559.379 324.054 314,423.887
202603 259,743.888 330.213 259,743.888

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ARS5,103.08 mean?
Merck (BUE:MRK) has a Cyclically Adjusted Book per Share of ARS5,103.08 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors.
Is Merck's Cyclically Adjusted Book per Share too high?
Merck's current Cyclically Adjusted Book per Share is ARS5,103.08. Overall, Merck has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merck's Cyclically Adjusted Book per Share compare to AMGN and ABBV?
Merck's Cyclically Adjusted Book per Share of ARS5,103.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors. Merck's current Cyclically Adjusted Book per Share is ARS5,103.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Based on GuruFocus' analysis, Merck (BUE:MRK) is currently considered Fairly Valued. The stock's GF Value™ is ARS36,249.74, compared to a current price of ARS38,720.00 — trading 6.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is ARS5,103.08. Merck's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Merck (BUE:MRK), the current Cyclically Adjusted Book per Share is ARS5,103.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (BUE:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of ARS38,720.00 is trading 6.8% above its estimated GF Value™ of ARS36,249.74. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for BUE:MRK:

  • Cyclically Adjusted Book per Share: ARS5,103.08
  • GF Value™: ARS36,249.74 vs. price of ARS38,720.00 (6.8% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the BUE:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
71GF Score

Get the complete analysis for BUE:MRK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS38,720.00
Price
ARS36,249.74
GF Value